According to a newly published market research report by 24LifeSciences, the global intracranial therapeutic market was valued at USD 8.45 billion in 2024 and is projected to reach USD 14.87 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period 20252032. Intracranial therapeutics encompass advanced pharmaceutical agents and medical interventions...